FinanceRecent
Symbiotec Pharmalab shares to list today; GMP signals 19% listing gain
Economic Times — Markets✓
Original Reporting
AI EXECUTIVE SUMMARY
The Symbiotec Pharmalab IPO plans to channel Rs 112.50 crore towards the prepayment and/or repayment, fully or partially, of select outstanding borrowings, helping strengthen the company’s balance sheet and potentially reduce its debt burden.
The Symbiotec Pharmalab IPO plans to channel Rs 112.50 crore towards the prepayment and/or repayment, fully or partially, of select outstanding borrowings, helping strengthen the company’s balance sheet and potentially reduce its debt burden.
This story was originally reported by Economic Times — Markets. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.